Regeneron Pharmaceuticals Inc. (REGN) Social Stream
REGENERON PHARMACEUTICALS INC (REGN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering REGENERON PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 16 | $850 | $565 | $683.266 | $739.95 | -7.66% |
| 2021-11-10 | 16 | $850 | $565 | $687.266 | $739.95 | -7.12% |
| 2021-11-19 | 16 | $850 | $565 | $697.266 | $739.95 | -5.77% |
| 2021-12-07 | 16 | $850 | $570 | $701.266 | $739.95 | -5.23% |
| 2021-12-09 | 18 | $850 | $570 | $704.312 | $739.95 | -4.82% |
| 2021-12-28 | 18 | $850 | $570 | $701.705 | $739.95 | -5.17% |
| 2022-01-03 | 18 | $850 | $570 | $705.812 | $739.95 | -4.61% |
| 2022-01-04 | 18 | $850 | $570 | $705.812 | $739.95 | -4.61% |
| 2022-01-05 | 18 | $850 | $570 | $699.562 | $739.95 | -5.46% |
| 2022-01-10 | 15 | $844 | $575 | $706.846 | $739.95 | -4.47% |
| 2022-01-21 | 15 | $844 | $575 | $704.384 | $739.95 | -4.81% |
| 2022-01-28 | 14 | $844 | $575 | $704.384 | $739.95 | -4.81% |
| 2022-02-07 | 14 | $843 | $575 | $704.153 | $739.95 | -4.84% |
| 2022-03-21 | 14 | $843 | $575 | $701.307 | $739.95 | -5.22% |
| 2022-04-04 | 13 | $843 | $565 | $695.583 | $739.95 | -6% |
| 2022-04-12 | 13 | $843 | $565 | $701.166 | $739.95 | -5.24% |
| 2022-05-04 | 11 | $780 | $565 | $688.727 | $739.95 | -6.92% |
| 2022-05-05 | 12 | $780 | $565 | $689.727 | $739.95 | -6.79% |
| 2022-05-18 | 12 | $780 | $565 | $686.454 | $739.95 | -7.23% |
| 2022-05-23 | 13 | $780 | $565 | $690.75 | $739.95 | -6.65% |
| 2022-06-03 | 15 | $780 | $550 | $687.416 | $739.95 | -7.1% |
| 2022-06-06 | 15 | $780 | $536 | $676.923 | $739.95 | -8.52% |
| 2022-08-02 | 16 | $780 | $536 | $665.785 | $739.95 | -10.02% |
| 2022-08-03 | 16 | $780 | $536 | $670 | $739.95 | -9.45% |
| 2022-08-04 | 17 | $788 | $536 | $667.5 | $739.95 | -9.79% |
| 2022-09-05 | 16 | $788 | $536 | $667.5 | $739.95 | -9.79% |
| 2022-09-14 | 18 | $925 | $550 | $750.066 | $739.95 | 1.37% |
| 2022-09-17 | 18 | $925 | $550 | $750.062 | $739.95 | 1.37% |
| 2022-09-26 | 18 | $925 | $550 | $757.187 | $739.95 | 2.33% |
| 2022-10-14 | 19 | $970 | $575 | $771.176 | $739.95 | 4.22% |
| 2022-10-17 | 19 | $970 | $575 | $770.555 | $739.95 | 4.14% |
| 2022-10-21 | 20 | $970 | $575 | $775.833 | $739.95 | 4.85% |
| 2022-11-03 | 21 | $970 | $575 | $779.789 | $739.95 | 5.38% |
| 2022-11-04 | 20 | $970 | $575 | $785.105 | $739.95 | 6.1% |
| 2022-11-11 | 21 | $970 | $550 | $786.736 | $739.95 | 6.32% |
| 2022-12-01 | 21 | $970 | $575 | $788.052 | $739.95 | 6.5% |
| 2022-12-15 | 21 | $970 | $595 | $789.105 | $739.95 | 6.64% |
| 2022-12-16 | 21 | $970 | $595 | $794.368 | $739.95 | 7.35% |
| 2023-01-04 | 21 | $970 | $595 | $801.833 | $739.95 | 8.36% |
| 2023-01-11 | 20 | $970 | $595 | $801.833 | $739.95 | 8.36% |
| 2023-01-23 | 20 | $970 | $595 | $801.833 | $739.95 | 8.36% |
| 2023-01-26 | 20 | $970 | $595 | $802.111 | $739.95 | 8.4% |
| 2023-01-27 | 20 | $970 | $605 | $802.666 | $739.95 | 8.48% |
| 2023-02-06 | 20 | $970 | $605 | $808.222 | $739.95 | 9.23% |
| 2023-02-13 | 22 | $970 | $605 | $812.5 | $739.95 | 9.8% |
| 2023-02-24 | 22 | $970 | $605 | $812.6 | $739.95 | 9.82% |
| 2023-03-09 | 22 | $970 | $605 | $813.55 | $739.95 | 9.95% |
| 2023-03-20 | 22 | $970 | $605 | $813.35 | $739.95 | 9.92% |
| 2023-03-23 | 22 | $970 | $605 | $816.3 | $739.95 | 10.32% |
| 2023-03-24 | 22 | $970 | $605 | $828.8 | $739.95 | 12.01% |
| 2023-03-28 | 22 | $1040 | $605 | $861.45 | $739.95 | 16.42% |
| 2023-03-30 | 22 | $1040 | $650 | $864.45 | $739.95 | 16.83% |
| 2023-03-31 | 22 | $1040 | $650 | $866.95 | $739.95 | 17.16% |
| 2023-04-05 | 22 | $1040 | $650 | $867.35 | $739.95 | 17.22% |
| 2023-04-12 | 22 | $1040 | $650 | $867.2 | $739.95 | 17.2% |
| 2023-04-18 | 22 | $1040 | $650 | $871.7 | $739.95 | 17.81% |
| 2023-05-03 | 22 | $1040 | $650 | $872.2 | $739.95 | 17.87% |
| 2023-05-05 | 22 | $1050 | $650 | $882 | $739.95 | 19.2% |
| 2023-05-31 | 22 | $1050 | $650 | $881.4 | $739.95 | 19.12% |
| 2023-06-02 | 21 | $1050 | $650 | $881.4 | $739.95 | 19.12% |
The Trend in the Analyst Price Target
Over the past 22 months, REGN's average price target has gone up $212.69.
Over the past 52 weeks, REGN's average upside potential has been 8.54%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-17 | 19 | 970 | 575 | 770.555 | 735.96 | 4.7% |
| 2022-10-21 | 20 | 970 | 575 | 770.555 | 713.91 | 7.93% |
| 2022-11-04 | 20 | 970 | 575 | 781.315 | 740.21 | 5.55% |
| 2023-04-18 | 22 | 1040 | 650 | 871.700 | 808.01 | 7.88% |
| 2023-04-24 | 22 | 1040 | 650 | 872.200 | 797.04 | 9.43% |
REGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.62 | 15 | 0 | 5 | 0 | 0 | 21 |
The Trend in the Broker Recommendations
Over the past 31 months, REGN's average broker recommendation rating improved by 0.38.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, REGENERON PHARMACEUTICALS INC's average analyst price target is higher than 7051.78% of them.
- In the context of Pharmaceutical Products stocks, REGENERON PHARMACEUTICALS INC's number of analysts covering the stock is greater than 6643.89% of them.
- REGENERON PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 757.37% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, REGENERON PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1866.89% of them.
In the Pharmaceutical Products industry, BMY, DNLI, and ARGX are the three stocks most similar to REGENERON PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for REGN? Use POWR Ratings for clearer insight into price direction.